Literature DB >> 12632374

Patent ductus arteriosus in micropreemies and full-term infants: the relative merits of surgical ligation versus indomethacin treatment.

Danny C Little1, Theodore C Pratt, Shannon E Blalock, Donald R Krauss, Donald R Cooney, Monford D Custer.   

Abstract

BACKGROUND/
PURPOSE: Treatment of ductus arteriosus is controversial. The merits and timing of ductus ligation versus indomethacin treatment were compared.
METHODS: Study parameters for infants with PDA (June 1988 through March 2001) included age, weight, physical findings, echocardiograph, success/complications of treatment, and length of stay (LOS). Statistical analysis was by descriptive univariate analysis.
RESULTS: Two hundred twelve infants were included. Median gestational age was 26 weeks (range, 22-38); weight, 836 g (447 to 2,863). Findings included murmur (94%), congestion (20%), cardiomegaly (15%), bounding pulses (6%), hyperdynamic precordium (4%), and CHF (2%). Echocardiographic measurements were left atrial diameter, 0.92 cm; posterior wall thickness, 0.26 cm; PDA diameter, 2.5 mm; septal thickness, 0.27 cm; aortic root diameter, 0.64 cm; ejection fraction, 39%; left ventricular internal diameter-diastole, 1.3 cm; left ventricular internal diameter-systole, 0.82 cm; right ventricular internal diameter-diastole, 0.51 cm. No measurement, except PDA diameter, was predictive of medical failure or need for reoperation. However, weight less than 1,000 g was highly predictive of medical failure. Additional cardiac anomalies included ASD (69%), VSD (3%), and aortic coarctation (1%). One hundred sixty-seven babies (79%) received indomethacin, closing the PDA in 88 cases (53%, recurrence = 47%). Indomethacin complications (73%) included thrombocytopenia (36%), BUN increase (31%), sepsis (30%), oliguria (25%), hyponatremia (25%), IVH (16%), pulmonary interstitial emphysema (11%), NEC (8%), intestinal perforation (4%), and bleeding (3%). Seventy-seven babies (36%) required operations (92% in the NICU) performed by pediatric surgeons. Ligation criteria included hypoxia, hypercapnia, decreasing compliance, CHF, and contraindications/failure of indomethacin. Complications included pneumothorax (4%), IVH (4%), bleeding (4%), NEC (1%), and wound infection (1%). LOS averaged 82 days.
CONCLUSIONS: Although indomethacin therapy is a reasonable treatment alternative, it is associated with significant complications. Ductus ligation may be preferable, especially in very low birth weight babies, because it is associated with low morbidity and almost certain degree of success. Copyright 2003, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12632374     DOI: 10.1053/jpsu.2003.50086

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  22 in total

1.  Improved closure of patent ductus arteriosus with high doses of ibuprofen.

Authors:  Udo Meißner; Raktima Chakrabarty; Hans-Georg Topf; Wolfgang Rascher; Michael Schroth
Journal:  Pediatr Cardiol       Date:  2012-02-04       Impact factor: 1.655

2.  Therapeutic strategies, including a high surgical ligation rate, for patent ductus arteriosus closure in extremely premature infants in a North American centre.

Authors:  Gregory P Moore; Sarah L Lawrence; Gyaandeo Maharajh; Amanda Sumner; Isabelle Gaboury; Nick Barrowman; Brigitte Lemyre
Journal:  Paediatr Child Health       Date:  2012-04       Impact factor: 2.253

3.  Determinants of surgical repair of patent ductus arteriosus in low-birth-weight infants.

Authors:  Yukako Yoshikane; Toshiko Mori; Toshiyuki Yoshizato; Yoshihiro Miyake; Shinichi Hirose
Journal:  J Med Ultrason (2001)       Date:  2011-05-28       Impact factor: 1.314

4.  Is surgical ligation of patent ductus arteriosus necessary? The Western Australian experience of conservative management.

Authors:  J M Brooks; J N Travadi; S K Patole; D A Doherty; K Simmer
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-05       Impact factor: 5.747

5.  Treatment of patent ductus arteriosus with bidirectional flow in neonates.

Authors:  Patrick N Ethington; P Brian Smith; Lakshmi Katakam; Ronald N Goldberg; C Michael Cotten
Journal:  Early Hum Dev       Date:  2011-03-12       Impact factor: 2.079

6.  Patent ductus arteriosus therapy: impact on neonatal and 18-month outcome.

Authors:  Juliette C Madan; Douglas Kendrick; James I Hagadorn; Ivan D Frantz
Journal:  Pediatrics       Date:  2009-02       Impact factor: 7.124

7.  Multiple courses of indomethacin and neonatal outcomes in premature infants.

Authors:  Madhavi Sangem; Sumita Asthana; Sanjiv Amin
Journal:  Pediatr Cardiol       Date:  2007-12-18       Impact factor: 1.655

8.  Vocal fold paralysis following surgical ductal closure in extremely low birth weight infants: a case series of feeding and respiratory complications.

Authors:  W F Malcolm; C Hornik; A Evans; P B Smith; C M Cotten
Journal:  J Perinatol       Date:  2008-11       Impact factor: 2.521

9.  Patent ductus arteriosus in premature neonates.

Authors:  Olachi J Mezu-Ndubuisi; Ghanshyam Agarwal; Aarti Raghavan; Jennifer T Pham; Kirsten H Ohler; Akhil Maheshwari
Journal:  Drugs       Date:  2012-05-07       Impact factor: 9.546

10.  Outcome following surgical closure of patent ductus arteriosus in very low birth weight infants in neonatal intensive care unit.

Authors:  Ga Yeun Lee; Young Bae Sohn; Myo Jing Kim; Ga Won Jeon; Jae Won Shim; Yun Sil Chang; June Huh; I-Seok Kang; Ji-Hyuk Yang; Tae-Gook Jun; Pyo Won Park; Won Soon Park; Heung Jae Lee
Journal:  Yonsei Med J       Date:  2008-04-30       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.